Professional Documents
Culture Documents
Benzophenones: Endocrine Disrupters
Benzophenones: Endocrine Disrupters
Benzophenones are the synthesized chemicals that block UV and are widely used in
inks, imaging, and clear coatings in the printing industry.
Related terms:
Endocrine Disrupters
Leping Ye, ... Ren-Shan Ge, in Vitamins & Hormones, 2014
4.2.5.7 Benzophenone
Of nine benzophenones (1–8 and 12) tested, benzophenone 1 is the most potent
inhibitor of human 17 -HSD3 activities with IC50 of 1 μM, while others have IC50s
around 47–111 μM (Nashev et al., 2010). Apparently, the inhibition of benzophe-
none 1 on human 17 -HSD3 activity is selective, since it inhibits 17 -HSD1 and
17 -HSD2 activities with IC50 values over 20 μM and has no inhibition on 17 --
HSD5 activity (Nashev et al., 2010). Rodent models also show that benzophenone 1
significantly inhibited testosterone production in mouse and rat testes (Nashev et
al., 2010).
(11)
(12)
(13)
> Read full chapter
26.2.3 Benzophenones
This category of sunscreen comprises a variety of ortho substituted benzophenones
with electron-donating groups that lead to increased electron delocalisation. The
spectrum of benzophenone (given in Fig. 6A) consists of a π–π* transition at 250 nm
and a much weaker ( 102 M−1 cm−1) n–π* transition at 350 nm, which is not shown.
The spectra of benzophenone derivatives used as sunscreens (Fig. 6B), however, are
shifted (to 325 nm) [7]. The principal benzophenone sunscreen in current use is
2-hydroxy-4-methoxybenzophenone (HM-BZP, its tradenames include Benzophe-
none-3 and Oxybenzone). A drawback with these filters is their comparatively low
absorption coefficients (only 9400 M−1 cm−1 at 325 nm for HM-BZP) and thus they
do not afford high sun protection factors (SPF) at low to moderate concentrations.
Also they offer only limited protection at longer UVA wavelengths.
Figure 6. Absorption spectra of benzophenone (A) in ethanol ( max = 251 nm, the
weak n–π* transition at 350 nm is not shown) and HM-BZP in ethanol (B).
3BZP* + RH → BZPH˙ + R˙
Garcinia cambogia
Rajinder Raina, ... Ramesh C. Gupta, in Nutraceuticals, 2016
Phytochemical Ingredients
G. cambogia is endowed with diverse phytochemical ingredients such as organic
acids, xanthones, polyisoprenylated benzophenones, and isoxanthohumols, some
of which are depicted in Figure 48.1. Various organic acids like HCA, citric tartaric,
and malic and succinic acid are isolated from this plant. HCA is the principal acid
present not only in fruit rinds of G. cambogia, but also in G. Indica and G. atrovidis.
Chemically, HCA is 1,2 di-hydroxy propane 1,2,3 tricarboxylic acid and is very similar
to citric acid found in oranges and other citrus fruits (Lewis and Neelakantan, 1965;
Jena et al., 2002).
Figure 48.1. Chemical structures of active phytochemical ingredients isolated from
Garcinia cambogia.
HCA molecule exists in four different isomers, which are (–)-HCA, (+)-HCA,
(–)-allo-HCA, and (+)-allo-HCA. The most potent inhibitor of ATP citrate lyase
(ACLY) is the (–)-HCA isomer, also known as 2S,3S–HCA (Stallings et al., 1979).
Commercially available G. cambogia extracts are prepared from the fruit rinds and
contain 20–60% (–)-HCA (Jena et al., 2002). HCA of high purity can be chemically
synthesized from citric acid. HCA can exist as a free acid or lactone form. (–)-HCA as
free acid is biologically active but chemically unstable, and gets converted into the
less biologically active but highly stable lactone form. The lactone form, because of
low bioavailability, is not therapeutically preferred. (–)-HCA is combined with various
counter ions to form single, double, or triple stable salts to prevent cyclization of
HCA into the lactone form and thus increase its solubility and bioavailability (Downs
et al., 2005). Sodium salt of HCA is physiologically more effective than the lactone
form, but it is highly hygroscopic and unfavorable for use in dietary supplements
in the dry form. Currently, double or triple salts of calcium, magnesium, and
potassium, instead of the single salt of HCA, are being used because of their
higher solubility and stability. HCA-SX or super CitriMax, which is a Ca+2/K+ salt
of (–)-HCA, is completely soluble in water, which confers higher bioavailability to it
(Downs et al., 2005). The fruit rind of G. cambogia is also rich in polyisoprenylated
benzophenones (Garcinol/comboginol), tetra cyclic xanthones (oxyguttiferones), and
isoxanthohumol (guttiferones I, J, K, M, and N) (Masullo et al., 2008). Garcinol is also
found in the latex and bark of the plant (Iinuma et al., 1998, Masullo et al., 2008). The
presence of phenolic hydroxyl groups and -diketone moiety in garcinol molecule
imparts strong antioxidant activity to it (Padhye et al., 2009). Garbogiol, a xanthone,
is found in the roots, whereas another xanthone, Rheediaxanthone A, is present in
the bark of the plant (Iinuma et al., 1998).
The propolis chemical composition variation is mainly due to the plant species
around the hive. Moreover, seasonal variations may occur in the number of com-
pounds present in propolis. These compounds are found in cuts, exudates, shoots,
resins, and others. Therefore, the biological properties of propolis are directly linked
to its botanical origin. In Europe, North America, West Asia and temperate countries,
the main source for propolis production is the poplar exudate (Populus sp.). These
countries possess only one type of propolis. However, in South America, the plant
of the genus Populus is not commonly found.
In 2008, the propolis popularly known as red propolis, found on the coast of Maceió,
Alagoas, was considered the 13th group, according to the previous proposed classif-
ication. Fig. 24.1 shows the crude Brazilian red propolis as produced on the beehive.
The red propolis of Alagoas has as its botanical origin the Dalbergia ecastophyllum, a
plant belonging to the Leguminosae family, the same family as soybeans and beans.
Several isolated compounds from this propolis are commonly found in plants of the
leguminosae family, which belongs to the botanical origin of red propolis [3].
Fig. 24.1. Propolis being produced in the beehive.
Among these groups, group 12, also known as green propolis, collected from the
Minas Gerais state, was the first to be distinguished due to its antimicrobial and
antiinflammatory properties. In addition, some patents regarding the obtaining
and usage of isolated bioactive compounds such as Artepelim C were granted
[12]. However, the red propolis is recently taking prominence due to its biological
properties and isolated compounds.
Red propolis can also be found in other countries such as Cuba, Mexico, and
Venezuela; however, Brazilian red propolis is more prominent in both consumption
and number of published works [13–16]. Within Brazil, the red propolis can be found
over Sergipe, Alagoas, Pernambuco, and Paraíba states. However, propolis from
different states shows slight differences in chemical composition and, consequently,
distinct biological activity [17–20].
Since Brazilian red propolis can be found in different Brazilian states, and due to
the prodigious Brazilian biodiversity, different chemical compounds can be found
in red propolis produced in various Brazilian states, even in neighboring states
such as Sergipe, Alagoas, Pernambuco, and Paraíba [3,20]. Fig. 24.2 illustrates the
geographical location of Brazilian red propolis.
Fig. 24.2. Geographical location (approximately) of Brazilian states that produce
Brazilian red propolis.
UV filters have been associated with adverse human reproductive health, pregnancy,
and birth outcomes. In a study conducted in the United States, creatinine concentra-
tions of two UV filters (2, 4-dihydroxybenzophenone and 2, 2 -dihydroxybenzophe-
none) were higher in women with fibroids than women without fibroids; however,
the odds were not significant after adjusting for relevant covariates (Pollack et al.,
2015). One study also showed that urinary concentrations of BP derivatives were
significantly associated with the odds of endometriosis diagnosis (Kunisue et al.,
2012). In the Longitudinal Investigation of Fertility and the Environment Study in
the United States, urinary levels of BP2 and 4-hydroxybenzophenone (a metabolite
of BP) in male partners were associated with reduced fecundity (longer time to
pregnancy) (Buck Louis et al., 2014a). Another report from this study showed that
BP2 and BP8 were significantly associated with some semen end points, including
diminished sperm concentration, movement, number of immature sperm, and
sperm tail abnormalities (Louis et al., 2015). In that study, maternal urinary level of
4-hydroxybenzophenone was also significantly associated with an excess of male
births, and both maternal and paternal urinary levels of BP2 were associated with an
excess of female births (Bae et al., 2016). In a study conducted in France, maternal
urinary levels of BP3 were positively associated with weight and head circumference
at birth in the male infants (Philippat et al., 2012). In a study conducted in New York
City, third-trimester maternal urinary levels of BP3 were inversely associated with
birth weight among girls, but positively associated with birth weight in boys (Wolff e
t al., 2008). In a study conducted in China, maternal urinary concentration of BP3
was associated with decreased gestational age in infants, especially in male infants
(Tang et al., 2013).
UV filter exposure induces reproductive toxicity in some, but not all animal studies.
BP3 (1525 mg/kg/day), OMC (935 mg/kg/day), and 4-MBC (309 mg/kg/day) have
been shown to increase uterine weight when rats were exposed through the diet
for 4 days (Schlumpf et al., 2001). In female rats, exposure to a metabolite of BP,
4-hydroxybenzophenone (3 days, 100–400 mg/kg/day) increased uterine weights,
luminal epithelial height, and thickness of vaginal epithelial cell layers (Nakagawa
and Tayama, 2001). Exposure to BP at 400 mg/kg/day, however, did not affect uterine
weight or the histology of the uterus and vagina. Furthermore, in a two-generation
rat study, dietary exposure to BP (100, 450, and 2000 ppm) did not affect estrous
cyclicity, reproductive capability, delivery and lactation, sperm parameters, serum
hormone levels, AGD, or number of pups delivered in F0 and F1 generations
(Hoshino et al., 2005).
OMC treatment (500, 750, and 1000 mg/kg/day) during gestation and lactation
reduced relative prostate and testis weights and testosterone levels, affected testis
and prostate histology on PND 16, and reduced sperm counts and prostate weight
at age of 8 months in male offspring (Axelstad et al., 2011). It also (1000 mg/kg/day)
reduced progesterone and estradiol levels on PND 28 in female offspring (Axelstad
et al., 2011).
In rats, exposure to 4-MBC during gestation every other day (100 mg/kg) signif-
icantly decreased GnRH, LH, and FSH levels in male offspring, but increased serum
LH and FSH levels and advanced vaginal opening in female offspring (Carou et al.,
2009a). When rats were exposed to 4-MBC daily during gestation, 4-MBC increased
LH (20, 100, and 500 mg/kg/day) and FSH (100 and 500 mg/kg/day) serum levels in
male offspring on PND 30, but decreased testicular weight, LH, and GnRH levels
(100 and 500 mg/kg/day) on PND 15 in males (Carou et al., 2009b). In another
study in which rats were exposed to 4-MBC during gestation, 4-MBC (7 mg/kg/day)
significantly increased tissue volume in prostate and accessory sex glands, the
number of ducts in the caudal dorsal prostate, distal branching morphogenesis,
and ductal volume on PND 1 (Hofkamp et al., 2008). Furthermore, continuous
exposure to 4-MBC from gestation to adulthood increased uterine weight, delayed
pubertal onset in males, reduced testis and prostate weights, disrupted several key
gene expression in uterus and prostate (Pr, Esr1, and Ar), affected sexual behaviors
(proceptive and receptive behaviors), and disrupted estrous cyclicity in rat offspring
(reviewed in Schlumpf et al., 2008).
Another series of structurally related biphenyl ether-based phenyl acetic acid CRTh2
antagonists includes 26, 27, and 28 (all IC50s < 300 nM) [44]. It is interesting to note
that the reverse amide, 27, and its analogous diphenyl methane, 28, both retain
CRTh2 affinity. These results suggest that the nature of the linker (benzamide vs.
anilide or ether vs. alkyl) is not crucial and, comparing to AMG-853, there seems
to be flexibility in the position of the linker relative to the acetic acid substituent
(i.e., meta versus para). The preferential use of the tert-butyl amide in both series of
compounds also suggests a similar binding mode to AMG-853.
A very potent series of biphenyl ether-containing phenyl acetic acid CRTh2 antago-
nists was recently disclosed [45]. Compounds 29–32 incorporate a 6-fluoro-3-methyl
naphthalene core and utilize either an ether (29; IC50 = 2.3 nM) or a keto-linker
without loss of affinity (31; IC50 = 2.1 nM) [46]. The terminal aryl sulfone can also
be replaced as a piperidinesulfonamide (32; IC50 = 2.4 nM), a common functional
group in many CRTh2 antagonists. In particular, compound 30, which incorporates
a bromo-substituted pyridine, demonstrates very high affinity for CRTh2 (IC50 = 0.02
nM).
Enzyme hydrolysis may be preferred when the analyte is acid-labile and high re-
covery is not an important factor, i.e. when sensitive detection and quantification
methodologies are incorporated in the overall protocols.
Specimen Pretreatment
Many drugs and their metabolites have strong affinity to proteins, whereas most of
their conjugates are highly hydrophilic and not amenable to organic solvent extrac-
tion. Thus, pretreatment procedures generally include the removal of the binding
proteins, the hydrolysis of drug conjugates, and the extraction of the analytes from
the resulting reaction mixture. Since urine has limited protein content, protein
removal is not necessary.
Drug conjugate hydrolysis: Acidic and enzymatic hydrolyses have their merits. For
example,
Enzymatic hydrolysis may be preferred when the analyte is acid-labile and high
recovery is not an important factor.
Extraction
This step typically removes interfering materials and concentrates the analyte.
Liquid–liquid extraction systems are designed to have the analyte partition, prefer-
ably into the organic phase in its unionized form or as an ion pair. The addition
of a proper counter ion or pH adjustment of the sample may be used to facilitate a
favorable partitioning of the drug. The analyte may also be ‘salted out’ of the aqueous
phase with high ionic strength of the medium. High concentrations of electrolytes
are used to generate the ionic strength of the medium in salting-out approaches.
Solid-phase extraction procedures widely adopted for the drug urinalyses include
four steps: (1) conditioning, (2) loading, (3) rinsing, and (4) eluting. The first con-
ditioning solvent should be as strong as, or stronger than the elution solvent. The
second conditioning solvent should be the same as or as close to the strength of
the loading solvent as possible. The loading solvent should be as weak as possible
to result in the tightest or narrowest band of adsorbed sample on the sorbent. A
solvent that is slightly stronger or the same strength as the loading solvent is used
as the rinse solvent. The rinse will elute unwanted sample components that are not
as strongly retained as the analytes and also wash down small droplets of loading
solvent adhering to the walls of the tube to ensure that the entire sample comes in
contact with the sorbent. An ideal eluting solvent should elute the analytes within
5–10 bed volumes. The optimal amount of solvent to elute the analytes from a
500-mg cartridge is about 0.6–1.2 ml. Using a too-strong solvent will cause the
elution of unnecessary sample components that are more strongly retained than the
analytes, whereas a too-weak solvent will cause excessive elution solvent volumes.
Sometimes, a desired solvent strength may be obtained by blending appropriate
amounts of miscible solvents.
If a water-immiscible eluant is selected and the analysis is to be performed with
the GC, a ‘drying’ procedure should be applied between the rinsing and the eluting
steps. The combination of vacuum and a small amount of methanol can produce a
‘dry’ eluate without causing a substantial loss of drugs.